文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气心脑血管急症

重型COVID-19后意识障碍的早期神经康复与恢复

Early Neurorehabilitation and Recovery from Disorders of Consciousness After Severe COVID-19.
PubMed 文献 · Neurocrit Care · 2021-10-05
一句话结论重型COVID-19后持续无反应患者中57%在出院前恢复至最小意识状态(CRS-R总分≥8),意识水平波动明显,需连续评估。

该研究在2020年3月10日至5月20日纽约市COVID-19疫情初期,对21例重型COVID-19后意识延迟恢复的ICU患者实施早期神经康复方案,包括系列修订版昏迷恢复量表(CRS-R)评估、多模态治疗和脑损伤医学专科会诊。出院前57%(12例)恢复至最小意识状态或更好(CRS-R总分≥8),中位恢复时间为停用持续镇静后8天。恢复组体重指数更低、峰值C反应蛋白更低、最低动脉血氧分压更高、芬太尼停用更早。CRS-R评分随时间波动,最佳总分显著高于最后一次总分(中位8 vs 5,p=0.002)。

要点

  • 21例重型COVID-19后意识延迟恢复患者接受ICU早期神经康复,出院前57%(12例)恢复至最小意识状态或更好(CRS-R总分≥8)。
  • 恢复至最小意识状态的患者中位在停用持续镇静后8天(IQR 2-14)恢复,提示镇静停用后仍需持续观察。
  • CRS-R评分随时间波动,最佳总分中位8(IQR 5-23)显著高于最后一次总分中位5(IQR 3-18),p=0.002,单次评估不足以判断预后。
  • 恢复组体重指数更低(p=0.009)、峰值C反应蛋白更低(p=0.023)、最低动脉血氧分压更高(p=0.028)、芬太尼停用更早(p=0.018)。
  • 芬太尼停用更早(p=0.001)和神经肌肉阻滞停用更早(p=0.015)与更高的最后一次CRS-R总分相关。

适用人群与场景

  • 2020年3月10日至5月20日纽约市COVID-19疫情初期,ICU中重型COVID-19后意识延迟恢复的患者21例参与了早期神经康复试点项目。
  • 研究对象为重型COVID-19后持续无反应、意识延迟恢复的ICU患者。

诊断标准与关键阈值

  • 恢复至最小意识状态或更好定义为出院前CRS-R总分≥8。

处置流程与药物剂量

  • 早期神经康复方案包括系列CRS-R评估、多模态治疗以及脑损伤医学专科医师的参与。
  • 患者出院前接受CRS-R评估的中位次数为6次(IQR 3-10),首次评估在入院后中位48天(IQR 40-55)开始。

研究设计与关键结果

  • 试点早期神经康复项目纳入21例重型COVID-19后意识延迟恢复患者,出院前57%(12例)恢复至最小意识状态或更好。
  • 恢复组体重指数更低(p=0.009)、峰值血清C反应蛋白更低(p=0.023)、最低动脉血氧分压更高(p=0.028)、芬太尼停用更早(p=0.018)。
  • CRS-R评分随时间波动,最佳CRS-R总分中位8(IQR 5-23)显著高于最后一次CRS-R总分中位5(IQR 3-18),p=0.002。
  • 芬太尼停用更早(p=0.001)和神经肌肉阻滞停用更早(p=0.015)与更高的最后一次CRS-R总分相关。

证据类型、等级与局限

  • 研究类型为试点早期神经康复项目,回顾性比较恢复与未恢复至最小意识状态或更好患者的临床特征。
  • 作者指出这些患者在ICU的早期神经康复可以实施,但伴随独特挑战。
  • 作者指出需要进一步研究评估与长期神经功能恢复相关的因素以及重型COVID-19患者早期康复的获益。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对重型COVID-19后意识延迟恢复的ICU患者,作者描述了在ICU实施早期神经康复方案(系列CRS-R评估、多模态治疗、脑损伤医学专科参与)的经验,作者指出该方案可以实施但伴随独特挑战。
  • 作者认为低氧、全身炎症、镇静和神经肌肉阻滞可能影响诊断评估和预后,意识水平的波动使连续评估成为必要。
  • 作者建议进一步研究评估与长期神经功能恢复相关的因素以及重型COVID-19患者早期康复的获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Early neurorehabilitation improves outcomes in patients with disorders of consciousness (DoC) after brain injury, but its applicability in COVID-19 is unknown. We describe our experience implementing an early neurorehabilitation protocol for patients with COVID-19-associated DoC in the intensive care unit (ICU) and evaluate factors associated with recovery.

METHODS: During the initial COVID-19 surge in New York City between March 10 and May 20, 2020, faced with a disproportionately high number of ICU patients with prolonged unresponsiveness, we developed and implemented an early neurorehabilitation protocol, applying standard practices from brain injury rehabilitation care to the ICU setting. Twenty-one patients with delayed recovery of consciousness after severe COVID-19 participated in a pilot early neurorehabilitation program that included serial Coma Recovery Scale-Revised (CRS-R) assessments, multimodal treatment, and access to clinicians specializing in brain injury medicine. We retrospectively compared clinical features of patients who did and did not recover to the minimally conscious state (MCS) or better, defined as a CRS-R total score (TS) ≥ 8, before discharge. We additionally examined factors associated with best CRS-R TS, last CRS-R TS, hospital length of stay, and time on mechanical ventilation.

RESULTS: Patients underwent CRS-R assessments a median of six (interquartile range [IQR] 3-10) times before discharge, beginning a median of 48 days (IQR 40-55) from admission. Twelve (57%) patients recovered to MCS after a median of 8 days (IQR 2-14) off continuous sedation; they had lower body mass index (p = 0.009), lower peak serum C-reactive protein levels (p = 0.023), higher minimum arterial partial pressure of oxygen (p = 0.028), and earlier fentanyl discontinuation (p = 0.018). CRS-R scores fluctuated over time, and the best CRS-R TS was significantly higher than the last CRS-R TS (median 8 [IQR 5-23] vs. 5 [IQR 3-18], p = 0.002). Earlier fentanyl (p = 0.001) and neuromuscular blockade (p = 0.015) discontinuation correlated with a higher last CRS-R TS.

CONCLUSIONS: More than half of our cohort of patients with prolonged unresponsiveness following severe COVID-19 recovered to MCS or better before hospital discharge, achieving a clinical benchmark known to have relatively favorable long-term prognostic implications in DoC of other etiologies. Hypoxia, systemic inflammation, sedation, and neuromuscular blockade may impact diagnostic assessment and prognosis, and fluctuations in level of consciousness make serial assessments essential. Early neurorehabilitation of these patients in the ICU can be accomplished but is associated with unique challenges. Further research should evaluate factors associated with longer-term neurologic recovery and benefits of early rehabilitation in patients with severe COVID-19.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Gurin L, Evangelist M, Laverty P, et al. Early Neurorehabilitation and Recovery from Disorders of Consciousness After Severe COVID-19. Neurocrit Care. 2021. PMID: 34611810. doi:10.1007/s12028-021-01359-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。